Osteodystrophy in chronic liver disease
Ugeskrift for Læger · 08.06.2026 · 1-7
DOI: 10.61409/v12230769 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, online erschienen am 08.06.2026. Verfasst von Pia Eiken und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endokrinologisk Afdeling, Københavns Universitetshospital - Bispebjerg Hospital. Hauptthemen laut MEDLINE: Liver Diseases, Bone Diseases, Metabolic. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Hepatic osteodystrophy is defined as a metabolic bone disease that may occur in individuals with chronic liver disease (CLD). Hepatic osteodystrophy commonly manifests with osteoporosis and fragility fractures. This review finds that patients older than 50 years with CLD should be screened for possible osteoporosis earlier if they experience fragility fractures. Treatment includes calcium, vitamin D, and lifestyle interventions. Bisphosphonates, such as alendronate, and denosumab increase bone mineral density in CLD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endokrinologisk Afdeling, Københavns Universitetshospital - Bispebjerg Hospital.
- Medicinsk Afdeling, Sjællands Universitetshospital, Slagelse.
- Gastroenterologisk afsnit, Abdominalcenter K, Københavns Universitet - Bispebjerg Hospital.
Zitieren
APA
Eiken, P., Al-Omran, A. A., & Schiødt, F. V. (2026). Osteodystrophy in chronic liver disease. Ugeskrift for Læger, 1-7. https://doi.org/10.61409/v12230769
Vancouver
Eiken P, Al-Omran AA, Schiødt FV. Osteodystrophy in chronic liver disease. Ugeskrift for Læger. 2026:1-7. doi:10.61409/v12230769
BibTeX
@article{Eiken2026,
author = {Eiken, Pia and Al-Omran, Atheer Adel and Schiødt, Frank Vinholt},
title = {Osteodystrophy in chronic liver disease},
journal = {Ugeskrift for Læger},
year = {2026},
pages = {1--7},
doi = {10.61409/v12230769}
}
EUVIMED